Forteo
- Product NDC
- 0002-8400
- 11-digit product format
- 000028400
- Labeler code
- 0002
- Product ID
- 0002-8400_31aeb334-c6d1-4018-af85-17ef69850001
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Teriparatide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Eli Lilly and Company
- Application
- NDA021318
- Marketing category
- NDA
- Marketing start
- 2002-11-26
- Marketing end
- 2027-02-02
- Substance
- TERIPARATIDE
- Active strength
- 250 ug/mL
- Pharmacologic classes
- Parathyroid Hormone Analog [EPC], Parathyroid Hormone [CS]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Forteo
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TERIPARATIDE | 250 ug/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 10T9CSU89I |
| Rxcui | 1435115, 1435117 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0002-8400-01 | Forteo | 2.24 mL in 1 SYRINGE | INJECTION, SOLUTION | 2.24 | | 42 |
| 0002-8400-01 | Forteo | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 42 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Teriparatide | ACTIVE INGREDIENT | 10T9CSU89I | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| Teriparatide | ACTIVE MOIETY | 10T9CSU89I | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| acetic acid | INACTIVE INGREDIENT | Q40Q9N063P | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| Metacresol | INACTIVE INGREDIENT | GGO4Y809LO | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| sodium acetate anhydrous | INACTIVE INGREDIENT | NVG71ZZ7P0 | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 23 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0002-8400 | FORTEO (TERIPARATIDE) INJECTION, SOLUTION [ELI LILLY AND COMPANY] | 40 | Current NDC, Legacy NDC, 2 package rows | 20241213_aae667c5-381f-4f92-93df-2ed6158d07b0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0002-8400-01 | 00002840001 | 1 SYRINGE in 1 CARTON (0002-8400-01) / 2.24 mL in 1 SYRINGE | 1 syringe | 2008-10-01 | 2027-02-02 | No | No | Current |